| Literature DB >> 26974303 |
Keith Sigel1, Robert Pitts1, Kristina Crothers2.
Abstract
Pulmonary malignancies are a major source of morbidity and mortality in HIV-infected persons. Non-AIDS-defining lung cancers (mostly non-small cell lung cancers) are now a leading cause of cancer death among HIV-infected persons. HIV-associated factors appear to affect the risk of lung cancer and may adversely impact cancer treatment and outcomes. HIV infection also may modify the potential harms and benefits of lung cancer screening with computed tomography. AIDS-defining lung malignancies include pulmonary Kaposi sarcoma and pulmonary lymphoma, both of which are less prevalent with widespread adoption of antiretroviral therapy. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26974303 PMCID: PMC5140273 DOI: 10.1055/s-0036-1578803
Source DB: PubMed Journal: Semin Respir Crit Care Med ISSN: 1069-3424 Impact factor: 3.119